These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. Jain A, Venkataramanan R, Sharma R, Kwong T, Orloff M, Abt P, Kashyap R, Tsoulfas G, Batzold P, Williamson M, Bozorgzadeh A. Transplantation; 2008 Feb 27; 85(4):554-60. PubMed ID: 18347534 [Abstract] [Full Text] [Related]
23. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area. Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM. Ann Surg; 2017 Jan 27; 265(1):173-177. PubMed ID: 28009743 [Abstract] [Full Text] [Related]
24. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Br J Surg; 2007 Jan 27; 94(1):78-86. PubMed ID: 17016793 [Abstract] [Full Text] [Related]
25. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma. Ninomiya M, Shirabe K, Facciuto ME, Schwartz ME, Florman SS, Yoshizumi T, Harimoto N, Ikegami T, Uchiyama H, Maehara Y. J Am Coll Surg; 2015 Mar 27; 220(3):297-304.e3. PubMed ID: 25617912 [Abstract] [Full Text] [Related]
26. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Li C, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Xu MQ, Wei YG. Hepatobiliary Pancreat Dis Int; 2010 Aug 27; 9(4):366-9. PubMed ID: 20688599 [Abstract] [Full Text] [Related]
27. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR. Liver Transpl; 2009 Dec 27; 15(12):1776-82. PubMed ID: 19938139 [Abstract] [Full Text] [Related]
28. Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients. Shen B, Chen B, Zhang W, Mao H, Shen C, Deng X, Zhan X, Chen H. Liver Transpl; 2009 Nov 27; 15(11):1473-80. PubMed ID: 19877254 [Abstract] [Full Text] [Related]
29. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases. Baccarani U, Adani GL, Bragantini F, Londero A, Comuzzi C, Rossetto A, Lorenzin D, Bresadola V, Risaliti A, Pea F, Toniutto P, Donini A, De Anna D, Bresadola F, Tavio M, Viale P. Transplant Proc; 2011 May 27; 43(4):1119-22. PubMed ID: 21620067 [Abstract] [Full Text] [Related]
30. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G. Liver Transpl; 2007 May 27; 13(5):733-40. PubMed ID: 17370330 [Abstract] [Full Text] [Related]
31. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy. Lei J, Yan L, Wang W. Eur J Gastroenterol Hepatol; 2013 Nov 27; 25(11):1340-6. PubMed ID: 23652915 [Abstract] [Full Text] [Related]
32. Results of pediatric living donor compared to deceased donor liver transplantation in the PELD/MELD era: Experience from two centers on two different continents. Yankol Y, Fernandez LA, Kanmaz T, Leverson GE, Mezrich JD, Foley D, Mecit N, D'Alessandro AM, Acarli K, Kalayoglu M. Pediatr Transplant; 2016 Feb 27; 20(1):72-82. PubMed ID: 26861217 [Abstract] [Full Text] [Related]
37. Living donor liver transplantation in patients older than 60 years. Yoshizumi T, Shirabe K, Soejima Y, Taketomi A, Yamashita N, Ikegami T, Uchiyama H, Kayashima H, Ninomiya M, Maehara Y. Transplantation; 2010 Aug 27; 90(4):433-7. PubMed ID: 20588207 [Abstract] [Full Text] [Related]
38. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J. Transplant Proc; 2009 Apr 27; 41(3):1041-3. PubMed ID: 19376421 [Abstract] [Full Text] [Related]
39. Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: A propensity score-matched analysis. Hilmi IA, Damian D, Al-Khafaji A, Sakai T, Donaldson J, Winger DG, Kellum JA. Liver Transpl; 2015 Sep 27; 21(9):1179-85. PubMed ID: 25980614 [Abstract] [Full Text] [Related]
40. Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models. Durand F, Belghiti J, Troisi R, Boillot O, Gadano A, Francoz C, de Hemptinne B, Mallet A, Valla D, Golmard JL. Liver Transpl; 2006 Feb 27; 12(2):231-9. PubMed ID: 16447208 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]